REPL and IOVA Related Headlines

Go Back

Jul 22, 2025 08:50AM Barclays Reiterates Overweight Rating on Replimune Group (REPL), PT $17, 'We see this as a clear positive for Iovance's Amtagvi'

REPL and IOVA Related Press Releases

Go Back

REPL and IOVA Related SEC Filings

Go Back